药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Amobarbital
The metabolism of Linagliptin can be increased when combined with Amobarbital.
Tetracosactide
Esketamine
The metabolism of Linagliptin can be increased when combined with Esketamine.
Tetracosactide
Lesinurad
The metabolism of Linagliptin can be increased when combined with Lesinurad.
Tetracosactide
Sarilumab
The metabolism of Linagliptin can be increased when combined with Sarilumab.
Tetracosactide
Eslicarbazepine acetate
The metabolism of Linagliptin can be increased when combined with Eslicarbazepine acetate.
Tetracosactide
Glycerol phenylbutyrate
The metabolism of Linagliptin can be increased when combined with Glycerol phenylbutyrate.
Tetracosactide
Armodafinil
The metabolism of Linagliptin can be increased when combined with Armodafinil.
Tetracosactide
Oritavancin
The metabolism of Linagliptin can be increased when combined with Oritavancin.
Tetracosactide
Quinoline Yellow WS
The risk or severity of angioedema can be increased when Linagliptin is combined with Quinoline Yellow WS.
Tetracosactide
Quinaprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Quinaprilat.
Tetracosactide
Perindoprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Perindoprilat.
Tetracosactide
Moexiprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Moexiprilat.
Tetracosactide
Trandolaprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Trandolaprilat.
Tetracosactide
Ramiprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Ramiprilat.
Tetracosactide
Fosinoprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Fosinoprilat.
Tetracosactide
Benazeprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Benazeprilat.
Tetracosactide
Saruplase
The risk or severity of angioedema can be increased when Linagliptin is combined with Saruplase.
Tetracosactide
Delapril
The risk or severity of angioedema can be increased when Linagliptin is combined with Delapril.
Tetracosactide
Zofenopril
The risk or severity of angioedema can be increased when Linagliptin is combined with Zofenopril.
Tetracosactide
Evogliptin
The risk or severity of angioedema can be increased when Linagliptin is combined with Evogliptin.